IKZF1 and myelodysplastic syndrome: Lenalidomide treatment degraded the transcription factors IKZF1 and IKZF3, which led to de-repression of GPR68 expression, increased Ca2+ concentration and activation of Ca2+-dependent calpain, resulting in cytotoxicity in MDS and acute myeloid leukemia cell lines [39].